- Home
- CSIQ vs KURA Comparison
CSIQ vs KURA Comparison
Compare CSIQ & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSIQ | KURA |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.4M | 841.6M |
| IPO Year | 2006 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CSIQ | KURA |
|---|---|---|
| Price | $18.61 | $10.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 11 |
| Target Price | $17.36 | ★ $25.56 |
| AVG Volume (30 Days) | ★ 3.2M | 1.8M |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,482,000.00 |
| Revenue This Year | $23.61 | $28.28 |
| Revenue Next Year | $13.90 | $106.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.24 |
| 52 Week Low | $9.41 | $5.45 |
| 52 Week High | $34.59 | $12.49 |
Technical Indicators
Market Signals| Indicator | CSIQ | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 56.79 |
| Support Level | $12.75 | $8.80 |
| Resistance Level | $21.07 | $11.17 |
| Average True Range (ATR) | 1.70 | 0.63 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 57.15 | 53.80 |
Price Performance
Historical ComparisonAbout CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.